CENTRAL GARDEN & PET COMPANY
8-K/A, 1997-07-14
MISCELLANEOUS NONDURABLE GOODS
Previous: PRUDENTIAL BANK & TRUST CO /GA/, 8-K, 1997-07-14
Next: CENTRAL GARDEN & PET COMPANY, S-3, 1997-07-14



<PAGE>
 
                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                 ______________


                                   FORM 8-K/A
                                AMENDMENT NO. 1

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OF 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934



Date of Report (Date of earliest event reported)          May 26, 1997
                                                 -------------------------------


                          Central Garden & Pet Company
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                     0-20242                  68-0275553
- --------------------------------    ----------------    ------------------------
  (State or other jurisdiction      (Commission File           (IRS Employer
      of incorporation)                Number)               Identification No.)
 

3697 Mt. Diablo Boulevard, Lafayette, California                       94549
- --------------------------------------------------------------------------------
(Address of principal executive offices)                             (Zip Code)



Registrant's telephone number, including area code         (510) 283-4573
                                                   -----------------------------


                                  Inapplicable
- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report)


Exhibit Index located on page 3
<PAGE>
 
          The purpose of this Form 8-K/A is to amend the Form 8-K, which was
filed on May 30, 1997, to provide the required financial statements.

Item 7.   Financial Statement and Exhibits
          --------------------------------

          (a)(1)    Financial Statements of the Sandoz Flea and Tick Protection
                    Business are attached as Exhibit 1.3 hereto.

          (a)(2)    Independent Auditors' Report is included in Exhibit 1.3
                    hereto.

          (b)(1)    Pro Forma Financial Information is attached as Exhibit 1.4
                    hereto.

          (c)       See attached Exhibit Index.

                                       2
<PAGE>
 
                                 EXHIBIT INDEX



Number         Exhibit
- ------         -------

1.1            Press Release dated May 26, 1997./*/

1.2            Amended and Restated Asset Purchase Agreement, dated as of
               February 3, 1997, as amended by Amendment No. 1 thereto, dated as
               of April 22, 1997, and Amendment No. 2 thereto, dated as of May
               23, 1997./*/

1.3            Financial Statements of the Sandoz Flea and Tick Protection
               Business (including Independent Auditors' Report).

1.4            Pro Forma Financial Information.

1.5            Independent Auditors' Consent.

- ----------------------- 

/*/   Incorporated by reference to Exhibits 1.1 and 1.2, respectively, of the
Company's Form 8-K Current Report filed on May 30, 1997.

                                       3
<PAGE>
 
                                   SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                              CENTRAL GARDEN & PET COMPANY



                              By /s/ Robert B. Jones
                                ------------------------------------
                                 Robert B. Jones, Vice President
                                 and Chief Financial Officer

Dated:  July 14, 1997

                                       4

<PAGE>
                                                                     EXHIBIT 1.3
 
INDEPENDENT AUDITORS' REPORT

Sandoz Agro, Inc.
Des Plaines, Illinois:

We have audited the accompanying statements of net assets to be acquired of the
Sandoz Flea and Tick Protection Business (the "Business"), a line of business
owned by Sandoz Agro, Inc. ("Sandoz Agro"), a wholly owned subsidiary of Sandoz
Ltd., as of September 30, 1996 and December 31, 1995 and the related statements
of revenues, direct expenses and identified corporate expenses before interest
and taxes for the nine months ended September 30, 1996 and the years ended
December 31, 1995 and 1994. These financial statements are the responsibility of
Sandoz Agro's management. Our responsibility is to express an opinion on these
financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such financial statements present fairly, in all material
respects, the net assets to be acquired of the Sandoz Flea and Tick Protection
Business as of September 30, 1996 and December 31, 1995 and the results of its
revenues, direct expenses and identified corporate expenses before interest and
taxes for the nine months ended September 30, 1996 and the years ended December
31, 1995 and 1994 in conformity with generally accepted accounting principles.

As discussed in Note 2 to the financial statements, the Sandoz Flea and Tick
Protection Business is a line of business owned by Sandoz Agro. The Business
receives managerial and administrative support from Sandoz Agro. Certain
expenses included in the financial statements represent allocations of amounts
applicable to Sandoz Agro. As a result, the Business' net assets to be acquired
and the results of its revenues, direct expenses and identified corporate
expenses before interest and taxes may not be indicative of conditions that
would have existed or results that would have occurred had the Business operated
as an unaffiliated entity.


DELOITTE & TOUCHE LLP


San Francisco, California
December 20, 1996
(May 23, 1997 as to Note 9)
<PAGE>
 
SANDOZ FLEA AND TICK PROTECTION BUSINESS
(A LINE OF BUSINESS OWNED BY SANDOZ AGRO, INC.)
 
STATEMENTS OF NET ASSETS TO BE ACQUIRED
MARCH 31, 1997 (UNAUDITED), SEPTEMBER 30, 1996
AND DECEMBER 31, 1995 (IN THOUSANDS)
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>

 
                                            MARCH 31,     SEPTEMBER 30,    DECEMBER 31,
                                               1997            1996            1995
                                           (UNAUDITED)
<S>                                        <C>            <C>              <C> 
ASSETS
 
CURRENT ASSETS:
  Inventories                                  $10,051           $19,271        $16,121
  Prepaid expenses and other assets                515               292            549
                                               -------           -------        -------

           Total current assets                 10,566            19,563         16,670
 
PROPERTY, PLANT AND EQUIPMENT - Net             10,439            10,826         11,473
                                               -------           -------        -------
 
TOTAL ASSETS                                    21,005            30,389         28,143
                                               -------           -------        -------
 
LIABILITIES
 
CURRENT LIABILITIES:
  Accounts payable                               1,961               764          1,883
  Accrued expenses                               3,261             3,722          4,375
                                               -------           -------        -------
 
           Total current liabilities             5,222             4,486          6,258
                                               -------           -------        -------
 
NET ASSETS TO BE ACQUIRED                      $15,783           $25,903        $21,885
                                               =======           =======        =======
</TABLE> 
 
See notes to financial statements.

                                      -2-
<PAGE>
 
SANDOZ FLEA AND TICK PROTECTION BUSINESS
(A LINE OF BUSINESS OWNED BY SANDOZ AGRO, INC.)
 
STATEMENTS OF REVENUES, DIRECT EXPENSES AND IDENTIFIED
CORPORATE EXPENSES BEFORE INTEREST AND TAXES
SIX MONTHS ENDED MARCH 31, 1997 (UNAUDITED),
NINE MONTHS ENDED SEPTEMBER 30, 1996
AND YEARS ENDED DECEMBER 31, 1995 AND 1994 (IN THOUSANDS)
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------------------------
 
                                             SIX MONTHS        NINE  MONTHS        YEARS ENDED 
                                               ENDED              ENDED            DECEMBER 31,
                                             MARCH 31,         SEPTEMBER 30,    ------------------
                                               1997               1996           1995       1994
                                            (UNAUDITED)
<S>                                           <C>               <C>             <C>        <C> 
NET SALES                                      $25,107           $54,866        $95,426    $87,808
 
COST OF SALES                                   17,803            21,266         35,587     33,194
                                               -------           -------        -------    -------
 
GROSS MARGIN                                     7,304            33,600         59,839     54,614
 
EXPENSES:
  Selling, general and administrative           11,797            22,000         32,059     30,733
  Research and development                       1,711             2,891          4,287      5,106
                                               -------           -------        -------    -------
 
INCOME (LOSS) BEFORE INTEREST
  AND TAXES                                    $(6,204)          $ 8,709        $23,493    $18,775
                                               =======           =======        =======    =======
</TABLE> 
 
See notes to financial statements.

                                      -3-
<PAGE>
 
SANDOZ FLEA AND TICK PROTECTION BUSINESS
(A LINE OF BUSINESS OWNED BY SANDOZ AGRO, INC.)

NOTES TO FINANCIAL STATEMENTS
SIX MONTHS ENDED MARCH 31, 1997 (UNAUDITED)
NINE MONTHS ENDED SEPTEMBER 30, 1996 AND
THE YEARS ENDED DECEMBER 31, 1995 AND 1994 (DOLLARS IN THOUSANDS)
- --------------------------------------------------------------------------------

1. ORGANIZATION AND OPERATIONS

   Sandoz Flea and Tick Protection Business (the "Business"), a line of business
   owned by Sandoz Agro, Inc. ("Sandoz Agro"), a wholly owned subsidiary of
   Sandoz Ltd., manufactures, packages, markets and distributes pest protection
   products for consumer, veterinary and professional pest management markets in
   the United States and Canada.  The Business includes manufacturing, research
   and administrative personnel in its manufacturing facility in Dallas, Texas
   as well as certain sales, marketing and administrative personnel located at
   the Sandoz Agro corporate headquarters in Des Plaines, Illinois.  Most of the
   customers of the Business are distributors.

2. BASIS OF PRESENTATION

   The Business is not a "stand-alone" division or subsidiary of Sandoz Agro and
   was not generally accounted for separately.  As a result, the distinct and
   separate accounts necessary to present individual balance sheets and income
   statements of the Business as of September 30, 1996 and December 31, 1995 and
   for the nine months ended September 30, 1996 and the years ended December 31,
   1995 and 1994 have not been maintained.

   The Business does not maintain stand-alone corporate treasury, legal, tax and
   other similar corporate support functions. Corporate general and
   administrative expenses have not been previously allocated to the Business.
   For purposes of preparing the financial statements, certain of these
   corporate costs along with other Sandoz Agro expenses were allocated using
   allocation methods (see Note 8). However, Sandoz Agro's systems and
   procedures do not provide sufficient information to develop a reasonable cost
   allocation for income taxes, corporate debt and interest expense.

   With respect to cash flows, purchases of inventory, payroll, capital and
   other expenditures are funded by Sandoz Agro.  Sales are billed and collected
   by Sandoz Agro.  Accordingly, the Business maintains only a minimal petty
   cash balance.

   FINANCIAL STATEMENT PRESENTATION - Due to the limitations noted above, the
   following financial information is presented:

   .      Statements of Net Assets to be Acquired.  These statements include
          only the net assets of the Business being purchased by Central Garden
          & Pet Company ("Central") (see Note 9).

   .      Statements of Revenues, Direct Expenses and Identified Corporate
          Expenses before Interest and Taxes, including all corporate cost
          allocations for which a reasonable method of allocating the costs to
          the operations can be developed.

   Statements of Cash Flows are not presented as the Business has essentially no
   cash flow.

                                      -4-
<PAGE>
 
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

   INVENTORIES - Inventories are stated at the lower of cost (first-in, first-
                 out) or market.

   PROPERTY, PLANT AND EQUIPMENT is recorded at cost.  Depreciation is provided
   using a straight line method over the estimated useful lives of the assets.
   The carrying amount of long-lived assets is evaluated annually to determine
   if adjustment to the depreciation period or to the unamortized balance is
   warranted.  Ranges of estimated useful lives for computing depreciation are
   as follows:

          Buildings and improvements                  3-40 years
          Machinery and equipment                     1-10 years
          Furniture and fixtures                      1-7 years

   REVENUE RECOGNITION - Sales are recorded at the date of shipment.

   USE OF ESTIMATES - The preparation of financial statements in conformity with
   generally accepted accounting principles requires management to make
   estimates and assumptions that affect the reported amounts of assets and
   liabilities and disclosure of contingent assets and liabilities and reported
   amounts of revenues and expenses during the reporting period.  Actual results
   could differ from those estimates.  Inventory reserves and corporate cost
   allocations of certain selling, general and administrative expenses represent
   significant estimates.

   INTERIM FINANCIAL STATEMENTS - The condensed financial statements as of and
   for the six months ended March 31, 1997 are unaudited.  These financial
   statements, in the opinion of Sandoz Agro, include all adjustments
   (consisting only of normal recurring adjustments) necessary for a fair
   presentation of the results for those interim periods.  The results of
   operations for the six months ended March 31, 1997 are not necessarily
   indicative of the results to be expected for the full year.

4. INVENTORIES

   Inventories include the following:
<TABLE>
<CAPTION>
 
                                             MARCH 31,       SEPTEMBER 30,   DECEMBER 31,
                                               1997              1996           1995    
                                            (UNAUDITED)                               
     <S>                                    <C>                 <C>             <C>         
     Raw materials and work in process         $ 6,238          $ 9,347        $ 7,962
     Finished goods                              3,813            9,924          8,159
                                               -------          -------        -------
                                                                                      
     Total                                     $10,051          $19,271        $16,121
                                               =======          =======        ======= 
</TABLE>

   Inventories were written down by approximately $6.5 million during the six
   months ended March 31, 1997 as the Business discontinued certain products.
   These writedowns occurred in certain product lines such as Zodiac, Nature
   Signature, Quick Strike, Starbar, and Specialty as a result of changes within
   the industry and significant increased competitive pressure from competing
   products such as Program, Frontline and Advantage.  Additionally, the Quick
   Strike product did not perform as intended.

                                      -5-
<PAGE>
 
5. PROPERTY, PLANT AND EQUIPMENT

   Property, plant and equipment includes the following:
<TABLE>
<CAPTION>
 
                                              SEPTEMBER 30,    DECEMBER 31,
                                                   1996            1995  
     <S>                                    <C>              <C>         
     Land                                        $  1,947        $  1,947
     Buildings and improvements                    14,299          14,166
     Machinery and equipment                       15,352          14,513
     Furniture and fixtures                         1,600           1,600
     Construction in progress                         725           1,303
                                                 --------        --------
                                                                         
                Total                              33,923          33,529
                                                                         
     Less accumulated depreciation                (23,097)        (22,056)
                                                 --------        --------
                                                                         
     Net property, plant and equipment           $ 10,826        $ 11,473
                                                 ========        ======== 
</TABLE>

   Purchases of property, plant and equipment for the nine months ended
   September 30, 1996 and the years ended December 31, 1995 and 1994 were $401,
   $1,486 and $844, respectively.  Depreciation expense for the nine months
   ended September 30, 1996 and the years ended December 31, 1995 and 1994 was
   $1,041, $1,591 and $2,054, respectively.

6. ACCRUED EXPENSES

   Accrued expenses includes the following:
<TABLE>
<CAPTION>
                                                                   
                                          SEPTEMBER 30,   DECEMBER 31,
                                               1996           1995 
     <S>                                   <C>            <C>      
     Accrued marketing allowances             $1,259         $2,152
     Accrued property taxes                      559            597
     Other                                     1,904          1,626
                                              ------         ------
                                                                   
     Total                                    $3,722         $4,375
                                              ======         ====== 
</TABLE>

   Other is primarily comprised of royalties, employee payroll and benefits,
   freight and other plant accruals, and sales tax.

7. EMPLOYEE BENEFIT PLANS

   Employees of the Business are participants in the Sandoz Agro sponsored
   defined benefit pension and postretirement health care benefit programs.
   Sandoz Agro allocates postretirement benefit costs to the Business as part of
   their corporate cost allocations.  The Sandoz Agro, Inc. Pension Plan is
   noncontributory with benefits related to an employee's length of service and
   compensation rate.  Postretirement health care benefits call for 50% cost
   sharing between Sandoz Agro and the participants.  Participants are eligible
   to receive these benefits through age 65.

   Pursuant to the terms of the Amended and Restated Asset Purchase Agreement
   (see Note 9) employees of Sandoz Agro that become employees of Central will
   be transferred from the Sandoz Agro defined 

                                      -6-
<PAGE>
 
   benefit pension plan, into a newly established Central defined benefit
   pension plan or a defined contribution plan that provides substantially
   equivalent benefits to the Sandoz Agro defined benefit plan. If the pension
   plan participants are transferred to a new defined benefit plan, Sandoz Agro
   is required to contribute assets to the new plan equivalent to the average of
   the accumulated benefit obligation and the projected benefit obligation at
   the closing date.

   Sandoz Agro employees are also eligible to participate in the Sandoz Agro,
   Inc. Savings Plan.  Sandoz Agro matches 100% of employee contributions up to
   6% of the employee's salary.  Pursuant to the terms of the Amended and
   Restated Asset Purchase Agreement (see Note 9) participants in the savings
   plan that transfer to Central will have their company matching contributions
   fully vested as of the closing date.

   Based upon the number of participants and their respective demographic data,
   the costs of postretirement benefits for the Business were as follows:
<TABLE>
<CAPTION>
                                                  NINE                      
                                               MONTHS ENDED    YEARS ENDED  
                                               SEPTEMBER 30,   DECEMBER 31, 
                                                              --------------
                                                   1996       1995      1994
     <S>                                      <C>             <C>       <C> 
     Pension expense:                                                       
       Defined benefit plan                        $216       $316      $253
       Defined contribution plan                    234        293       291
     Postretirement health care benefits             59        100       101 
</TABLE>

   As of September 30, 1996, the estimated accumulated benefit obligation and
   projected benefit obligation related to the participants of the Business in
   the Sandoz Agro defined benefit pension plan was $2,987 and $4,691,
   respectively.  The discount rate assumption used to determine the accumulated
   benefit obligation and the projected benefit obligation as of September 30,
   1996 was 7.75%.  The salary increase assumption used to determine the
   projected benefit obligation as of September 30, 1996 was 4.5%.

   As of September 30, 1996, the estimated accumulated postretirement benefit
   obligation for the participants of the Business in the Sandoz Agro
   postretirement health care benefit program was $377.  The discount rate used
   to determine the accumulated postretirement benefit obligation as of
   September 30, 1996 was 7.75%.

8. CORPORATE ALLOCATIONS

   The Business does not maintain stand-alone corporate treasury, legal, tax and
   other similar corporate support functions.  The Business does record certain
   corporate expenses related primarily to employee payroll and benefits,
   insurance and corporate facilities costs.  For purposes of preparing the
   financial information for the Business, certain expenses of Sandoz Agro were
   allocated based upon a variety of factors which include sales of the
   Business, the number of employees of the Business, and the identification of
   costs specifically attributable to the Business.  Management believes that
   these allocations are based on assumptions that are reasonable under the
   circumstances; however, the Business' net assets to be acquired and the
   results of revenues, direct expenses and identified corporate expenses before
   interest and taxes may not be indicative of conditions that would have
   existed or results that would have occurred had the Business operated as an
   unaffiliated entity.

                                      -7-
<PAGE>
 
   The following represents a summary of the corporate costs allocated to the
   Business which were included in the Statements of Revenues, Direct Expenses
   and Identified Corporate Expenses before Interest and Taxes:
<TABLE>
<CAPTION>
                                                                             
                                                  NINE                       
                                              MONTHS ENDED    YEARS ENDED    
                                              SEPTEMBER 30,   DECEMBER 31,   
                                                            -----------------
                                                  1996       1995      1994  
     <S>                                      <C>           <C>       <C>    
     Selling, general and administrative         $8,070     $12,417   $13,074 
</TABLE>

9. SALE OF THE SANDOZ FLEA AND TICK PROTECTION BUSINESS

   On February 3, 1997, Novartis Inc. ("Novartis") (successor by merger to
   Sandoz Ltd.), the parent company of Sandoz Agro, entered into an Amended and
   Restated Asset Purchase Agreement (which was amended on April 22, 1997 and
   May 23, 1997) with Central whereby Central agreed to purchase certain assets
   and intellectual properties and assume certain liabilities of the Business
   for $31,000.  The sale of the Business closed on May 23, 1997.

   In connection with the Amended and Restated Asset Purchase Agreement,
   Novartis and Central entered into a Toll Manufacturing Agreement.  Under the
   terms of the Toll Manufacturing Agreement, for up to two years, Novartis will
   purchase from Central, and Central will sell to Novartis certain products
   historically manufactured by the Business and sold to other Sandoz Ltd.
   affiliates.  No minimum quantities of annual production of products or
   minimum purchase quantities are set forth or implied in the Toll
   Manufacturing Agreement, and no penalties will be imposed on Novartis for not
   purchasing such products.

   Under the terms of a Transition Services Agreement, Novartis will provide
   management information systems, customer service, and financial and other
   administrative services support to Central for up to three months at fees
   based upon actual hours incurred, the cost of Novartis personnel, actual
   travel expenses, and any costs to Novartis in providing such services.

   Pursuant to the terms of the Amended and Restated Asset Purchase Agreement,
   Novartis is liable for all product claims on products manufactured prior to
   the closing date of the acquisition.  Additionally, Central is indemnified
   for a period of 25 years for any environmental contingencies associated with
   the Business that existed as of the closing date.

10. TRANSACTIONS WITH RELATED PARTIES

   Sales to affiliates of Sandoz Ltd. for the nine months ended September 30,
   1996 and the years ended December 31, 1995 and 1994 were $2,110, $3,826 and
   $1,408, respectively. Purchases of inventory from Sandoz Ltd. affiliates for
   the nine months ended September 30, 1996 and the years ended December 31,
   1995 and 1994 were $4,037, $6,555 and $6,425, respectively.

                                     ******

                                      -8-

<PAGE>
 
                                                                     EXHIBIT 1.4

              UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION

Central Garden & Pet Company's (the "Company") acquisition of the Sandoz Flea
and Tick Protection Business ("Sandoz Flea and Tick") will be accounted for
under the "purchase" method of accounting which requires the purchase price to
be allocated to the acquired assets and liabilities assumed of Sandoz Flea and
Tick on the basis of their estimated fair values as of the date of acquisition.
The following unaudited pro forma consolidated condensed balance sheet gives
effect to the acquisition of Sandoz Flea and Tick as if it occurred on March 29,
1997 and the pro forma consolidated condensed statements of income give effect
to the acquisition as if it occurred on October 1, 1995 and include adjustments
directly attributable to the acquisition and expected to have a continuing
impact on the combined company (collectively, the "Unaudited Pro Forma Financial
Information"). As the Unaudited Pro Forma Financial Information has been
prepared based on preliminary estimates of fair values, amounts actually
recorded may change upon determination of the total purchase price and
additional analysis of individual assets acquired and liabilities assumed.

The Unaudited Pro Forma Financial Information and related notes are provided for
informational purposes only and are not necessarily indicative of the 
consolidated financial position or results of operations of the Company as they 
may be in the future or as they might have been had the acquisition been
effected on the assumed dates. The Unaudited Pro Forma Financial Information 
should be read in conjunction with the historical consolidated financial 
statements of the Company, and the related notes thereto, which are included in 
the Company's Annual Report on Form 10-K for the year ended September 28, 1996 
and the Company's Quarterly Results on Form 10-Q, for the six months ended March
29, 1997, and the historical financial statements of Sandoz Flea and Tick, and 
the related notes thereto, presented elsewhere in this Current Report on Form 
8-K. See Exhibit 1.3 attached hereto.
<PAGE>
 
UNAUDITED PRO FORMA CONSOLIDATED CONDENSED BALANCE SHEET
MARCH 29, 1997
(In thousands)
<TABLE>
<CAPTION>
                                                                                  Pro Forma for the Sandoz
                                                             Historical           Flea and Tick Acquisition
                                                      --------------------------  -------------------------
                                                       Central       Sandoz
                                                        Garden    Flea and Tick   Adjustments      Combined
                                                      ----------  -------------   -----------     ---------
<S>                                                     <C>       <C>                 <C>           <C>    
ASSETS:
  Cash                                                $  14,843                   $  (6,000)(a)   $   8,843
  Inventories                                           270,722   $  10,051           4,092 (b)     284,865
  Other current assets                                  135,598         515             (85)(c)     136,028
  Land, buildings, improvements and equipment - net      15,950      10,439          (4,700)(d)      21,689
  Other assets                                           86,643                      23,735 (e)     110,378
                                                      ---------   ---------       ---------       ---------
      Total                                           $ 523,756   $  21,005       $  17,042       $ 561,803
                                                      =========   =========       =========       =========

LIABILITIES AND SHAREHOLDERS' EQUITY:
  Current liabilities                                 $ 261,636   $   5,222       $  32,448 (f)   $ 299,306
  Long-term debt                                        117,025                                     117,025
  Deferred items                                          1,670                         377 (g)       2,047
  Shareholders' equity                                  143,425      15,783         (15,783)(h)     143,425
                                                      ---------   ---------       ---------       ---------
      Total                                           $ 523,756   $  21,005       $  17,042       $ 561,803
                                                      =========   =========       =========       =========
</TABLE>
<PAGE>
 
Notes to Unaudited Pro Forma Consolidated Condensed Balance Sheet
- -----------------------------------------------------------------
<TABLE>

<S>                                                                                                              <C>     
(a)  Adjustment to eliminate cash used to acquire Sandoz Flea and Tick.

(b)  Includes $4.2 million of methoprene inventory held by Novartis Inc. to be
     delivered at a later date and an adjustment to record acquired inventories
     at estimated fair value.

(c)  To eliminate trade account balances between the Company and Sandoz Flea and
     Tick.

(d)  Adjustment to record acquired property, plant and equipment at estimated
     fair value.

(e)  Adjustment to record the excess of purchase price over the estimated fair
     value of identifiable net assets acquired as computed below:

      Cash paid to Sandoz Agro                                                                                   $ 31,000
      Total estimated direct fees and expenses in connection with acquisition                                       3,600
                                                                                                                 --------
         Total purchase price                                                                                    $ 34,600
                                                                                                                 ========

      Preliminary allocation of purchase price:
         Inventories                                                                                             $ 14,143
         Other current assets                                                                                         430
         Property, plant and equipment                                                                              5,739
         Current liabilities                                                                                      (14,727)
         Postretirement benefit liability                                                                            (377)
         Excess of purchase price over the estimated fair value of identifiable net assets acquired                29,392
                                                                                                                 --------
         Total purchase price                                                                                    $ 34,600
                                                                                                                 ========

      Excess of purchase price over the fair value of identifiable net assets acquired                           $ 29,392
      Down payment made to Sandoz Agro in February 1997                                                            (5,000)
      Direct fees and expenses paid through March 29, 1997 in connection with acquisition                            (657)
                                                                                                                 --------
         Net adjustment                                                                                          $ 23,735
                                                                                                                 ========

(f)   Adjustment to reflect the following:

      To eliminate trade account balances between the Company and Sandoz Flea and Tick                           $    (85)
      To accrue for severance costs associated with contractual obligations for former Sandoz Agro employees        5,100
      To accrue for prior Sandoz Agro product registration and other commitments with no future benefit to the
         Company                                                                                                    2,390
      To accrue for costs associated with exiting certain activities of the acquired business                       1,600
      To adjust sales returns allowance to conform with the Company's policy                                          500
      To accrue direct fees and expenses in connection with the acquisition of Sandoz Flea and Tick                 2,943
      To record line of credit borrowings to finance the acquisition of Sandoz Flea and Tick                       20,000
                                                                                                                 --------
         Net adjustment                                                                                          $ 32,448
                                                                                                                 ========

(g)  Adjustment to record the Sandoz Flea and Tick accumulated postretirement
     benefit obligation.

(h)  Adjustment to eliminate Sandoz's invested capital in Sandoz Flea and Tick.
</TABLE>
<PAGE>
 
UNAUDITED PRO FORMA CONSOLIDATED CONDENSED STATEMENT OF INCOME
FOR THE FISCAL YEAR ENDED SEPTEMBER 28, 1996
(In thousands, except per share data)
<TABLE>
<CAPTION>

                                                                                                              Pro Forma
                                                                       Pro Forma for the Sandoz              Adjustments
                                                    Historical        Flea and Tick Acquisition               for the   
                                               ---------------------- ------------------------- Historical  Four Paws and          
                                                Central    Sandoz                               Four Paws       Kenlin     Pro Forma
                                                Garden  Flea and Tick Adjustments     Combined  and Kenlin   Acquisitions  Combined
                                               -------- ------------- -----------     -------- -----------  -------------- --------
                                                                                     
<S>                                            <C>        <C>         <C>             <C>        <C>          <C>          <C>     
Net sales                                      $619,622   $ 73,304    $ (3,149)(a)    $689,777   $ 86,411     $ (6,005)(e) $770,183
Cost of goods sold and occupancy                535,189     28,222      (5,179)(b)     558,232     55,744       (4,133)(f)  609,843
                                               --------   --------    --------        --------   --------     --------     --------
Gross profit                                     84,433     45,082       2,030         131,545     30,667       (1,872)     160,340
Selling, general and administrative expenses     66,945     29,021         422 (c)      96,388     20,159       (1,917)(g)  114,630
Research and development expenses                            3,991                       3,991                                3,991
                                               --------   --------    --------        --------   --------     --------     --------
Income from operations                           17,488     12,070       1,608          31,166     10,508           45       41,719
Interest and other expenses                       3,023                  1,800 (d)       4,823        377        2,659 (h)    7,859
                                               --------   --------    --------        --------   --------     --------     --------
Income before income taxes                       14,465     12,070        (192)         26,343     10,131       (2,614)      33,860
Income taxes                                      6,017                  4,941 (i)      10,958      4,235       (1,841)(i)   13,352
                                               --------   --------    --------        --------   --------     --------     --------
Net income                                     $  8,448   $ 12,070    $ (5,133)       $ 15,385   $  5,896     $   (773)    $ 20,508
                                               ========   ========    ========        ========   ========     ========     ========
                                                                                   
Net income per common and common 
equivalent share:
   Primary                                     $   0.72                               $   1.31                             $   1.50
   Fully diluted                               $   0.71                               $   1.29                             $   1.48

Weighted average common and common equivalent
   shares outstanding:
   Primary                                       11,702                                 11,702                   1,965 (j)   13,667
   Fully diluted                                 11,904                                 11,904                   1,965 (j)   13,869
</TABLE>
<PAGE>
 
Notes to Unaudited Pro Forma Consolidated Condensed Statement of Income
- -----------------------------------------------------------------------
<TABLE>
<S>                                                                                                                      <C>
(a)   Adjustment to eliminate historical sales from Sandoz Flea and Tick to the Company.

(b)   Adjustment to eliminate cost of sales for historical sales from Sandoz Flea and Tick to the Company.              $(3,149)
      To adjust for the reduced price of methoprene purchased from Novartis Inc. in connection with the
         methoprene supply agreement entered into in connection with the acquisition of Sandoz Flea and Tick.            (2,030)
                                                                                                                        -------
         Net adjustment                                                                                                 $(5,179)
                                                                                                                        =======

(c)   Adjustment to reflect the amortization of the excess of purchase price over the fair value of identifiable
         net assets acquired.  The excess of the purchase price over the fair value of identifiable net assets
         acquired is amortized over 40 years.                                                                           $   735
      Adjustment to reduce building lease expense as a result of former Sandoz Agro administrative employees
         being required to move out of the Sandoz Agro corporate headquarters to another leased facility.                  (313)
                                                                                                                        -------
         Net adjustment                                                                                                 $   422
                                                                                                                        =======

(d)   Interest expense for line of credit borrowings to finance the acquisition of Sandoz
         Flea and Tick.

(e)   Adjustment to eliminate historical sales from Four Paws to the Company.

(f)   Adjustment to eliminate cost of sales for historical sales from Four Paws to the Company.                         $(6,005)
      Adjustment to reclassify certain Kenlin costs to conform with the Company's policy.                                 1,872
                                                                                                                        -------
         Net adjustment                                                                                                 $(4,133)
                                                                                                                        =======

(g)   Reduction in operating lease costs in connection with lease agreement entered into with the former owner
         of Four Paws.                                                                                                  $  (464)
      Reduction in salary expense in connection with employment agreement entered into with the former owner
         of Four Paws.                                                                                                     (574)
      Amortization of the excess of purchase price over the fair value of identifiable net assets of Four Paws
         acquired.  The excess of the purchase price over the fair value of the identifiable net assets of Four Paws
         acquired is amortized over 40 years.                                                                               869
      Amortization of the excess of purchase price over the fair value of identifiable net assets of Kenlin acquired.
         The excess of the purchase price over the fair value of identifiable net assets of Kenlin acquired is
         amortized over 40 years.                                                                                           114
      Adjustment to reclassify certain Kenlin costs to conform with the Company's policy.                                (1,862)
                                                                                                                        -------
         Net adjustment                                                                                                 $(1,917)
                                                                                                                        =======

(h)   To increase interest expense associated with the issuance of 6% convertible subordinated notes issued to
         finance the acquisition of Four Paws.                                                                          $ 2,700
      To reduce interest expense on note payable to former shareholder required to be repaid in connection with
         the acquisition of Four Paws.                                                                                      (41)
                                                                                                                        -------
         Net adjustment                                                                                                 $ 2,659
                                                                                                                        =======

(i)   Adjustment to the historical provision for income taxes to give effect to the pro forma adjustments discussed
         above and to record a provision for income taxes for Sandoz Flea and Tick.

(j)   To record issuance of common shares of the Company's common stock to acquire Four Paws and Kenlin.
</TABLE>
<PAGE>
 
UNAUDITED PRO FORMA CONSOLIDATED CONDENSED STATEMENTS OF INCOME
FOR THE SIX MONTHS ENDED MARCH 29, 1997
(In thousands, except per share data)
<TABLE> 
<CAPTION> 
                                                                                                            
                                                                       Pro Forma for the Sandoz              Pro Forma
                                                    Historical        Flea and Tick Acquisition             Adjustments
                                               ---------------------- -------------------------              for the
                                                Central    Sandoz                               Historical   Four Paws    Pro Forma
                                                Garden  Flea and Tick Adjustments     Combined   Four Paws   Acquisitions  Combined
                                               -------- ------------- -----------     ---------  ----------  ------------  --------
<S>                                            <C>      <C>           <C>             <C>       <C>         <C>            <C> 
Net sales                                      $336,485  $  25,107     $    (715)(a)  $ 360,877  $   6,880   $  (1,368)(e) $366,389
Cost of goods sold and occupancy                285,315     17,803        (1,300)(b)    301,818      3,561      (1,368)(e)  304,011
                                               --------  ---------     ---------      ---------  ---------   ---------       ------
Gross profit                                     51,170      7,304           585         59,059      3,319          --       62,378
Selling, general and administrative expenses     42,844     11,797           289 (c)     54,930      3,067        (569)(f)   57,428
Research and development expenses                            1,711                        1,711                               1,711
Write-off of goodwill                                                                                1,402                    1,402
                                               --------  ---------     ---------      ---------  ---------   ---------       ------
Income (loss) from operations                     8,326     (6,204)          296          2,418     (1,150)        569        1,837
Interest and other expenses                       2,747                    1,010 (d)      3,757        (54)        610 (g)    4,313
                                               --------  ---------     ---------      ---------  ---------   ---------       ------
Income (loss) before income taxes                 5,579     (6,204)         (714)        (1,339)    (1,096)        (41)      (2,476)

Income taxes (benefit)                            2,348                   (2,913)(h)       (565)       164        (269)(h)     (670)

                                               --------  ---------     ---------      ---------  ---------   ---------     --------
Net income (loss)                              $  3,231  $  (6,204)    $   2,199      $    (774) $  (1,260)  $     228     $ (1,806)

                                               ========  =========     =========      =========  =========   =========     ========

Net income per common and common 
equivalent share:
   Primary                                     $   0.21                               $   (0.05)                           $  (0.12)

   Fully diluted                               $   0.21                               $   (0.05)                           $  (0.12)


Weighted average common and common equivalent
   shares outstanding:
   Primary                                       15,200                                  15,200                    282 (i)   15,482
   Fully diluted                                 15,284                                  15,284                    282 (i)   15,566
</TABLE>
<PAGE>
 
Notes to Unaudited Pro Forma Consolidated Condensed Statement of Income
- -----------------------------------------------------------------------
<TABLE>

<S>                                                                                                                    <C>   
(a)   Adjustment to eliminate historical sales from Sandoz Flea and Tick to the Company.

(b)   Adjustment to eliminate cost of sales for historical sales from Sandoz Flea and Tick to the Company.             $  (715)
      To adjust for the reduced price of methoprene purchased from Novartis Inc. in connection with the
         methoprene supply agreement entered into in connection with the acquisition of Sandoz Flea and Tick.             (585)
                                                                                                                       -------
         Net adjustment                                                                                                $(1,300)
                                                                                                                       =======

(c)   Adjustment to reflect the amortization of the excess of purchase price over the fair value of identifiable
         net assets acquired.  The excess of the purchase price over the fair value of identifiable net assets
         acquired is amortized over 40 years.                                                                          $   367
      Adjustment to reduce building lease expense as a result of former Sandoz Agro administrative employees
         being required to move out of the Sandoz Agro corporate headquarters to another leased facility.                  (78)
                                                                                                                       -------
         Net adjustment                                                                                                $   289
                                                                                                                       =======

(d)   Interest expense for line of credit borrowings to finance the acquisition of Sandoz Flea                         $   900
         and Tick.
      To reduce interest income on proceeds of 6% convertible subordinated notes used to finance a portion of the
         acquistion of Sandoz Flea and Tick.                                                                               110
                                                                                                                       -------
         Net adjustment                                                                                                $ 1,010
                                                                                                                       =======

(e)   Adjustment to eliminate sales and cost of sales for historical sales from Four Paws to the Company.

(f)   Reduction in operating lease costs in connection with lease agreement entered into with the former owner
         of Four Paws.                                                                                                 $  (116)
      Reduction in salary expense in connection with employment agreement entered into with the former owner
         of Four Paws.                                                                                                    (144)
      Amortization of the excess of purchase price over the fair value of identifiable net assets of Four Paws
         acquired.  The excess of the purchase price over the fair value of the identifiable net assets of Four Paws
         acquired is amortized over 40 years.                                                                              217
      Elimination of forgiveness of loans to Four Paws shareholder and family in connection with the asset purchase
         agreement between the Company and Four Paws.                                                                     (526)
                                                                                                                       -------
         Net adjustment                                                                                                $  (569)
                                                                                                                       =======

(g)   To increase interest expense associated with the issuance of 6% convertible subordinated notes issued to
         finance the acquisition of Four Paws.                                                                         $   355
      To reduce interest expense on note payable to former shareholder required to be repaid in connection with
         the acquisition of Four Paws.                                                                                     (10)
      To reduce interest income on proceeds of 6% convertible subordinated notes used to finance the acquisition of
         Four Paws.                                                                                                        265
                                                                                                                       -------
         Net adjustment                                                                                                $   610
                                                                                                                       =======

(h)   Adjustment to the historical provision for income taxes to give effect to the pro forma adjustments discussed
         above and to record a provision for income taxes for Sandoz Flea and Tick.

(i)   To record issuance of common shares of the Company's common stock to acquire Four Paws.

</TABLE>

<PAGE>
                                                                     EXHIBIT 1.5













INDEPENDENT AUDITORS' CONSENT



We consent to the incorporation by reference in Central Garden & Pet Company's
Registration Statements Nos. 333-09865, 333-01238, 33-96816, 33-89216 and
33-72326 on Forms S-8, Nos. 333-05261 and 333-22209 on Forms S-4 and Nos.
33-86284 and 333-21603 on Forms S-3 of our report on the Sandoz Flea and Tick
Protection Business dated December 20, 1996 (May 23, 1997 as to Note 9)
appearing in this Current Report on Form 8-K/A of Central Garden & Pet Company.

DELOITTE & TOUCHE LLP


San Francisco, California
July 11, 1997





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission